BIO: Mr. Amit D. Munshi has been the Chief Executive Officer and President of Arena Pharmaceuticals, Inc. since May 11, 2016. Mr. Munshi served as an Interim Principal Financial Officer of Arena Pharmaceuticals, Inc. from May 11, 2016 to June 15, 2016. Prior to Arena Pharmaceuticals, he served as the Chief Executive Officer and President of EPIRUS Biopharmaceuticals, Inc. from July 15, 2014 to May 6, 2016. Mr. Munshi served as the President and Chief Executive Officer at Percivia LLC (Sold To Johnson & Johnson) from 2011 to 2012. He co-founded Kythera Biopharmaceuticals, Inc. in 2005 and served as its Chief Business Officer and Advisor from 2005 to 2010. He was an Advisor of Cynvenio Biosystems, Inc. He held leadership positions at Amgen Inc. Globally In Multiple Product Management, General Management and Corporate Development Positions from 1997 to 2005, including General Manager of European Nephrology. He has more than 25 years of pharmaceutical and biotechnology experience, including general management, product development, licensing and business development. Mr. Munshi serves on the boards of Oxeia Biopharmaceuticals, Inc., and Cytrellis Biosystems, Inc., both privately held companies. He has been a Director at Arena Pharmaceuticals, Inc. since June 13, 2016. He has been a Director at Pulmatrix, Inc. since June 2017. He served as a Director at Cynvenio Biosystems, Inc. since August 3, 2011. He served as a Director of EPIRUS Biopharmaceuticals, Inc. since July 15, 2014 until May 6, 2016. Mr. Munshi holds a BA in History and a BS in Economics from the University of California at Riverside and an MBA from the Peter F. Drucker & Masatoshi Ito Graduate School of Management at Claremont Graduate University.

Michel Vounatsos

CEO of Biogen

BIO: Mr. Michel Vounatsos has been the Chief Executive Officer of Biogen Inc. since January 6, 2017. Mr. Vounatsos served as the Chief Commercial Officer and Executive Vice President of Biogen Inc. since April 18, 2016 until December 2016. He is a sophisticated global business leader who has a track record of commercial success and creativity. He joined Biogen after a 20 year career at Merck, where he various positions including served as president, Primary Care Business Line and Merck Customer Centricity. Prior to this role, he held leadership positions at Merck across Europe and in China. He has been Director of Biogen Inc. since January 6, 2017. Mr. Vounatsos attended the Universite Victor Segalen, Bordeaux II, in France, receiving his C.S.C.T. certificate in Medicine. He received his M.B.A. from the HEC School of Management in Paris.